Delivery Order SPE2DR25D2006-SPE2DR26F57FB
Award Date 1/8/26
Potential Completion Date 1/9/26
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp provides for the supply of Celebrex 200 mg capsules (100 count) with a ceiling value of $2,995.19 under a firm fixed price arrangement. The contract is not set aside and was competitively awarded by the Medical Supply Chain, a component of the Defense Logistics Agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Celebrex 200 mg capsule in unit dose packaging (100 count) under a firm fixed-price contract valued at $4,985.13. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg under a firm fixed-price contract valued at $20,551.98. The award, made on September 24, 2025, represents a non-competitive delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Celecoxib 200 mg capsules (500-count units) valued at $1,575.46. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,503.49 for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory medication. This non-set-aside, firm fixed price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a typical transactional purchase under the company's...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,563,043,087 units of the medication Celecoxib 200 mg Capsule, with a total ceiling value of $1,103.10. The contract is a firm fixed-price delivery order with a period of performance through December 11, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg, a nonsteroidal anti-inflammatory drug commonly used for pain management and arthritis treatment. This firm fixed-price delivery order, valued at $2,727.36, was awarded on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract represents a non-set-aside procurement executed through open competition, and performance will be fulfilled at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $361,252.95 delivery order is for the supply of 4,531,831,739 units of the pharmaceutical drug Celecoxib 200mg. The award is for delivery by October 7, 2015 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $146,665.05 Firm Fixed Price Delivery Order is for the supply of 4536207533 CELEBREX 200MG 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves...